Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...

The global drug delivery solutions market is poised for significant growth, with an estimated value of USD 113.3 million in ...

While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.

The FDA will review a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive ...

First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old.The virus-like particle (VLP) single-dose chikungunya ...

Fill-Finish Manufacturing Market growth is driven by the increasing demand for biologics, vaccines, and injectable pharmaceuticals, alongside advancements in automation and robotics.Pune, Jan. 29, ...

The syringe filling machine industry is experiencing significant growth due to the increasing demand for injectable medications, particularly with the rise of biologics, vaccines, and precision ...

GSK and the University of Oxford have launched the GSK-Oxford Cancer Immuno-Prevention Programme, a new research initiative focused on cancer preve ...

GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix (GSK’s Recombinant ...

Fifteen European countries have secured an agreement with the American COVID-19 vaccine manufacturer Moderna through the European Commission f ...

Moderna won an agreement for its Covid vaccines in Europe on Friday, but Moderna stock reversed its early gains.